Global Interoperability Leader Lyniate Rebrands as Rhapsody
Company Reaffirms Commitment to Corepoint Technology and Customers
Boston, MA – April 3, 2023 – Lyniate, a global leader in healthcare data interoperability, has rebranded as Rhapsody®. The company, founded as Rhapsody in 2018, changed its name to Lyniate in 2019 following its merger with Corepoint Health. After four years, the company has elected to return to the Rhapsody name to leverage the brand’s global recognition, trademark protection, and distribution channels.
As part of the decision, leadership has reaffirmed its deep commitment to both the Corepoint and Rhapsody integration engine technology teams and customer bases, and to all of the technologies and customers that have come into the organization through merger activity, including CareCom, NextGate, and Datica’s integration business. Going forward, the company will use the Rhapsody brand for its suite of interoperability solutions and will maintain the Corepoint brand for the Corepoint Integration Engine component of the suite.
“We aim to pragmatically address every data-sharing challenge that hampers improved outcomes,” said Michelle Blackmer, chief market officer at Rhapsody. “We believe that uniting the products under a common brand umbrella better represents how customers use the solutions. Rhapsody health solutions work together to deliver faster time to value at a lower total cost of ownership. At the time of the Corepoint merger, launching a new brand was the best way to demonstrate our commitment to both platforms, which we see as complementary components of a comprehensive interoperability suite. After nearly four years, that commitment to Corepoint technology and customers is well established, so returning to the Rhapsody name, with its established recognition and infrastructure, is a practical choice.”
The Rhapsody name is known around the world as a pioneer and leader in healthcare interoperability. Today, the company remains at the forefront of the field, driving efforts to solve the interoperability challenges that are top-of-mind for healthcare stakeholders. The company’s Rhapsody® and Corepoint® solutions secured the top spots in the Integration Engine category for the 14th consecutive year in the 2023 Best in KLAS®: Software & Services report, cementing their unprecedented leadership in that category.
“We have made a series of strategic mergers and acquisitions over the last four years that have allowed us to offer the most comprehensive and effective interoperability suite in healthcare,” said Erkan Akyuz, chief executive officer at Rhapsody. “We remain committed to each of these solutions and their customers. The decision to revert to the Rhapsody brand is not meant to express any different level of commitment to one brand over another. It is simply the most efficient way to achieve our goals.”
The Rhapsody Interoperability Suite includes top-ranked HL7 and API integration capabilities; Rhapsody Identity, a proven, best-of-breed Enterprise Master Person Index (EMPI) and provider registry; and Rhapsody Semantic, a combined terminology solution, authoring tool, and FHIR terminology service. This comprehensive, market-leading portfolio maintains an over 99% customer retention rate and top-tier NPS score for helping healthcare delivery organizations, health networks, payers, and public health power more meaningful data exchange.
To set up a meeting with a Rhapsody executive at the upcoming HIMSS conference taking place in Chicago April 17-21, visit Booth 7110 or contact us.
About Rhapsody:
Rhapsody partners with healthcare organizations around the globe delivering its adaptable Interoperability Suite to reliably connect, classify, and clean data. Rhapsody health solutions power the applications and workflows that improve clinical, operational, and financial outcomes today while helping teams respond to and prepare for changes on the horizon. Rhapsody is committed to empowering people throughout the healthcare ecosystem, from specialty clinics to large care networks, from public health to health technology, and everything in between.